Government Medical College, Kozhikode
Kozhikode, Kerala 673008
3 studies enrolling now · 11 studies all time
What they study most
Cardiovascular Disease, Chronic Kidney Disease, Complicated Intra-abdominal Infection, Diabetes Mellitus, Type 2, Diabetes Type 2, Heart Failure, Hosptial Acquired Pneumonia, Immunoglobulin A Nephropathy (IgAN), Obesity, Sickle Cell Disease, Type 2 Diabetes, Ventilator Associated Pneumonia
Studies at this site
- A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN) — Recruiting now
- A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease — Recruiting now
- A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease — Recruiting now
- Research Study Investigating How Well NDec Works in People With Sickle Cell Disease — Completed
- REDEFINE 3: A Research Study to See the Effects of CagriSema in People Living With Diseases in the Heart and Blood Vessels — Running, not enrolling
- A Research Study to See How Well CagriSema Helps People With Excess Body Weight Lose Weight — Running, not enrolling
- A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation — Running, not enrolling
- A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor — Completed
- Effect of Retatrutide Compared With Placebo in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise Alone (TRANSCEND-T2D-1) — Completed
- A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly Insulin Icodec — Completed
- A Study to Determine the Efficacy, Safety and Tolerability of Aztreonam-Avibactam (ATM-AVI) ± Metronidazole (MTZ) Versus Meropenem (MER) ± Colistin (COL) for the Treatment of Serious Infections Due to Gram Negative Bacteria. — Completed